Nuveen Multi Cap Value Fund Class A
NQVAX
NASDAQ
| Weiss Ratings | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C+ | |||
| Risk Index | Good | |||
| Risk Grade | B | |||
| Company Info | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Nuveen | |||
| Manager/Tenure (Years) | Jon D. Bosse (27), Jujhar S. Sohi (5) | |||
| Website | http://www.nuveen.com | |||
| Fund Information | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Nuveen Multi Cap Value Fund Class A | |||
| Category | Mid-Cap Value | |||
| Sub-Category | US Equity Large Cap Value | |||
| Prospectus Objective | Growth | |||
| Inception Date | Dec 09, 2002 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 2,500.00 | |||
| Minimum Subsequent Investment | 100.00 | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.24% | |||
| Dividend | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.51% | |||
| Asset Allocation | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 3.74% | |||
| Stock | 96.25% | |||
| U.S. Stock | 83.76% | |||
| Non-U.S. Stock | 12.49% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.95% | |||
| 30-Day Total Return | 6.44% | |||
| 60-Day Total Return | 9.12% | |||
| 90-Day Total Return | 12.07% | |||
| Year to Date Total Return | 6.70% | |||
| 1-Year Total Return | 15.67% | |||
| 2-Year Total Return | 33.44% | |||
| 3-Year Total Return | 59.25% | |||
| 5-Year Total Return | 132.30% | |||
| Price | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $58.10 | |||
| 1-Month Low NAV | $54.58 | |||
| 1-Month High NAV | $58.10 | |||
| 52-Week Low NAV | $47.36 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $58.69 | |||
| 52-Week High Price (Date) | Nov 25, 2024 | |||
| Beta / Standard Deviation | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.88 | |||
| Standard Deviation | 15.80 | |||
| Balance Sheet | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 520.23M | |||
| Operating Ratios | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.16% | |||
| Turnover Ratio | 24.00% | |||
| Performance | NQVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 20.77% | |||
| Last Bear Market Total Return | -13.52% | |||